Literature DB >> 17103345

Respiratory symptoms and smoking behaviour in Swiss conscripts.

David Miedinger1, Prashant N Chhajed, Christoph Karli, Gianpiero A Lupi, Jörg D Leuppi.   

Abstract

AIM: Smoking is a major health hazard in young adults. Reducing smoking is the only well established effective primary prevention of chronic obstructive pulmonary disease. We undertook a prospective cross sectional study to determine the prevalence of respiratory symptoms, smoking behaviour and willingness to participate in a smoking cessation program in Swiss conscripts.
METHODS: Conscripts completed a standardized questionnaire on respiratory symptoms, asthma and smoking behaviour and underwent spirometry measurement.
RESULTS: 2604 conscripts were included. 1252 (48%) were current smokers, 144 (6%) were former smokers, 111 (4%) were recent beginners or low intensity smokers and 1097 (42%) were never smokers. Respiratory symptoms were significantly higher in smokers compared to never smokers (wheezing 16% vs. 7%, wheezing without cold 9% vs. 4%, exercise dyspnoea 15% vs. 10%, regular cough 35% vs. 10% and regular phlegm 15% vs. 2%). The mean score of the Fagerstrom Test for Nicotine Dependency (FTND) was 2.6 (+/-2.1). According to the transtheoretical model of stage of change 50% were in the precontemplation, 34% in the contemplation, 5% in the preparation, 5% in the action and 6% in the maintenance stage. Amongst the current smokers 33% were willing to participate in a smoking cessation program. Those willing to participate in a smoking cessation program included 17% precontemplators and 53% contemplators.
CONCLUSION: There is a high prevalence of respiratory symptoms in young current smokers. The Fagerstrom Test for Nicotine Dependence score in conscripts is low thus favouring a potentially successful outcome of a smoking cessation intervention. Using motivational stages to tailor smoking cessation aids might preclude adequate interventions in individuals belonging to the precontemplation stage.

Entities:  

Mesh:

Year:  2006        PMID: 17103345     DOI: 2006/41/smw-11544

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  6 in total

1.  Cigarette smokers' intention to quit smoking in Dire Dawa town Ethiopia: an assessment using the Transtheoretical Model.

Authors:  Eshetu Girma; Tsion Assefa; Amare Deribew
Journal:  BMC Public Health       Date:  2010-06-08       Impact factor: 3.295

2.  Predictors of respiratory symptoms in a rural Canadian population: A longitudinal study of respiratory health.

Authors:  Chandima P Karunanayake; Donna C Rennie; Punam Pahwa; Yue Chen; James A Dosman
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

3.  Prevalence, correlates of and perceptions toward cigarette smoking among adolescents in South Korea.

Authors:  Emmanuel Rudatsikira; Adamson S Muula; Seter Siziya
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

4.  Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel.

Authors:  Sang Min Lee; Jong Seong Ahn; Chang Suk Noh; Sei Won Lee
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

5.  Prevalence and factors associated with difficulty and intention to quit smoking in Switzerland.

Authors:  Pedro Marques-Vidal; João Melich-Cerveira; Fred Paccaud; Gérard Waeber; Peter Vollenweider; Jacques Cornuz
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

6.  Prevalence of asthma-like symptoms with ageing.

Authors:  Debbie Jarvis; Roger Newson; Christer Janson; Angelo Corsico; Joachim Heinrich; Josep M Anto; Michael J Abramson; Anne-Marie Kirsten; Jan Paul Zock; Roberto Bono; Pascal Demoly; Bénédicte Leynaert; Chantal Raherison; Isabelle Pin; Thorarinn Gislason; Rain Jogi; Vivi Schlunssen; Cecilie Svanes; John Watkins; Joost Weyler; Antonio Pereira-Vega; Isabel Urrutia; Jose A Gullón; Bertil Forsberg; Nicole Probst-Hensch; H Marike Boezen; Jesús Martinez-Moratalla Rovira; Simone Accordini; Roberto de Marco; Peter Burney
Journal:  Thorax       Date:  2017-10-03       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.